Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
- PMID: 20101529
- PMCID: PMC3129743
- DOI: 10.1007/s12035-009-8095-7
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
Abstract
Mitochondria are dynamic organelles that undergo continuous fission and fusion, which could affect all aspects of mitochondrial function. Mitochondrial dysfunction has been well documented in Alzheimer's disease (AD). In the past few years, emerging evidence indicates that an imbalance of mitochondrial dynamics is involved in the pathogenesis of AD. In this review, we discuss in detail the abnormal mitochondrial dynamics in AD and how such abnormal dynamics may impact mitochondrial and neuronal function and contribute to the course of disease. Based on this discussion, we propose that mitochondrial dynamics could be a potential therapeutic target for AD.
Similar articles
-
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.J Neurochem. 2009 May;109 Suppl 1(Suppl 1):153-9. doi: 10.1111/j.1471-4159.2009.05867.x. J Neurochem. 2009. PMID: 19393022 Free PMC article. Review.
-
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.J Alzheimers Dis. 2013;33 Suppl 1(0 1):S253-62. doi: 10.3233/JAD-2012-129005. J Alzheimers Dis. 2013. PMID: 22531428 Free PMC article. Review.
-
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488. Cells. 2019. PMID: 31121890 Free PMC article. Review.
-
Mitochondrial dysfunction and Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20624441 Review.
-
Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.Mol Neurobiol. 2018 Feb;55(2):1004-1018. doi: 10.1007/s12035-017-0385-x. Epub 2017 Jan 13. Mol Neurobiol. 2018. PMID: 28084594
Cited by
-
Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.Ann Integr Mol Med. 2019;1(1):61-74. Epub 2019 Nov 20. Ann Integr Mol Med. 2019. PMID: 31858090 Free PMC article.
-
Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth.Mol Cell. 2015 Feb 5;57(3):537-51. doi: 10.1016/j.molcel.2015.01.002. Mol Cell. 2015. PMID: 25658205 Free PMC article.
-
Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation.Neurobiol Aging. 2013 Oct;34(10):2399-2407. doi: 10.1016/j.neurobiolaging.2013.04.014. Epub 2013 May 21. Neurobiol Aging. 2013. PMID: 23702344 Free PMC article.
-
Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.Mol Neurobiol. 2012 Aug;46(1):136-50. doi: 10.1007/s12035-012-8271-z. Epub 2012 May 3. Mol Neurobiol. 2012. PMID: 22552779 Review.
-
Dynamin-Related Protein 1 at the Crossroads of Cancer.Genes (Basel). 2018 Feb 21;9(2):115. doi: 10.3390/genes9020115. Genes (Basel). 2018. PMID: 29466320 Free PMC article. Review.
References
-
- Blass JP. The mitochondrial spiral. An adequate cause of dementia in the Alzheimer’s syndrome. Ann N Y Acad Sci. 2000;924:170–183. - PubMed
-
- Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimer’s Dis. 2006;9:147–153. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous